Humane Genomics
Developer of a synthetic virology platform designed to engineer oncolytic viral therapies for cancer treatment. The company's platform offers RNA-based viral therapies with selective infection, high l...
Valuation
$17M
Latest known
Share Price
N/A
Total Raised
$8.1M
Last Round
N/A